Back to RXRX
XPONANCE LLC RXRX Position History
Recursion Pharmaceuticals, Inc.
Quarters held
5
Latest value
$228K
Q3 2026
Peak value
$228K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $146K |
| Q4 2025 | $128K |
| Q1 2026 | $127K |
| Q2 2026 | $185K |
| Q3 2026 | $228K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $228K | 55.2K | — | — |
| Q2 2026 | $185K | 50.4K | — | — |
| Q1 2026 | $127K | 41.2K | — | — |
| Q4 2025 | $128K | 31.3K | — | — |
| Q3 2025 | $146K | 30.0K | — | — |